Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakihana, M.
Right arrow Articles by Nagaoka, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakihana, M.
Right arrow Articles by Nagaoka, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLINE BITARTRATE
*CHOLINE CHLORIDE
*GLUCOSE

Stroke, Vol 19, 217-222, Copyright © 1988 by American Heart Association


ARTICLES

Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia

M Kakihana, N Fukuda, M Suno and A Nagaoka
Biology Laboratories, Takeda Chemical Industries, Limited, Osaka, Japan.

The effects of cytidine 5'-diphosphocholine (CDP-choline) on neurologic deficits and cerebral glucose metabolism were studied in a rat model of transient cerebral ischemia. Cerebral ischemia was induced by occluding both common carotid arteries for 20 or 30 minutes 24 hours after the vertebral arteries were permanently occluded by electrocautery. CDP- choline was administered intraperitoneally twice daily for 4 days after reestablishing carotid blood flow. CDP-choline at two dosages (50 and 250 mg/kg) shortened the time required for recovery of spontaneous motor activity in a dose-related manner; recovery time was measured early after reperfusion. Neurologic signs were observed for 10 days. High-dose CDP-choline improved neurologic signs in the rats within 20- 30 minutes of ischemia. When cerebral glucose metabolism was assessed on Day 4, increases in the levels of glucose and pyruvate were accompanied by decreases in the synthesis of labeled acetylcholine from uniformly labeled [14C]glucose measured in the cerebral cortex of rats with 30 minutes of ischemia. High-dose CDP-choline also attenuated changes in these variables. CDP-[1,2-14C]choline injected intravenously 10 minutes after reperfusion was used for membrane lipid biosynthesis. These results indicate that CDP-choline has beneficial effects on brain dysfunction induced by cerebral ischemia, which may be due in part to the restorative effects of CDP-choline on disturbed cerebral glucose metabolism, probably by stimulating phospholipid biosynthesis.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. M. Adibhatla, J. F. Hatcher, E. C. Larsen, X. Chen, D. Sun, and F. H. C. Tsao
CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke
J. Biol. Chem., March 10, 2006; 281(10): 6718 - 6725.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. M. Clark, L. R. Wechsler, L. A. Sabounjian, and U. E. Schwiderski
A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients
Neurology, November 13, 2001; 57(9): 1595 - 1602.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. M. Clark, B. J. Williams, K. A. Selzer, R. M. Zweifler, L. A. Sabounjian, and R. E. Gammans
A Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke
Stroke, December 1, 1999; 30(12): 2592 - 2597.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Lipton
Ischemic Cell Death in Brain Neurons
Physiol Rev, October 1, 1999; 79(4): 1431 - 1568.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Andersen, K. Overgaard, P. Meden, G. Boysen, and S. C. Choi
Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model • Editorial Comment
Stroke, July 1, 1999; 30(7): 1464 - 1471.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Clark, L. Gunion-Rinker, N. Lessov, K. Hazel, and R. L. Macdonald
Citicoline Treatment for Experimental Intracerebral Hemorrhage in Mice • Editorial Comment
Stroke, October 1, 1998; 29(10): 2136 - 2140.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Z. Onal, F. Li, T. Tatlisumak, K. W. Locke, B. W. Sandage Jr, and M. Fisher
Synergistic Effects of Citicoline and MK-801 in Temporary Experimental Focal Ischemia in Rats
Stroke, May 1, 1997; 28(5): 1060 - 1065.
[Abstract] [Full Text]